Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Hardware & electrical equipment

Broadcom, Qualcomm, Miragen Therapeutics, Savara Inc and more - AFTER HOURS

A brief look at pre-market trade before the bell In New York

It was a record finish on Friday, with the Dow Jones closing up over 440 points

In pre-market deals, a stock on the move is Broadcom Ltd (NYSE:AVGO), which surged 2.65% to US$260.50 after the Wall Street Journal reported that chip giant Intel Corp (NASDAQ:INTC) is considering a bid for the group.

It comes as Broadcom pursues a hostile takeover of rival Qualcomm Inc (NASDAQ:QCOM) in recent months, which has so far been rebuffed.

BREAKING: Intel, under threat, is considering a possible bid for Broadcom https://t.co/G61jG4v4k5

— WSJ Tech (@WSJTech) 9 March 2018

Broadcom, the Singapore-based semiconductor company, also said it expects to complete its redomicilation to the US by April 3 this year.

Before the bell, Qualcomm shares are up 1.14% to US$63.75.

Elsewhere, Oclaro Inc (NASDAQ:OCLR) shares added over 24% in pre-market to US$9.74 after telecoms firm Lumentum Holdings Inc (NASDAQ:LITE) announced plans to acquire the group for US$9.99 per share in cash and shares.

Miragen Therapeutics Inc (NASDAQ:MGEN) shares added 6.56% to US$7.31 in pre-market trading after gaining 6.52% to US$6.86 on Friday.

On the losing front, Savara Inc (NASDAQ:SVRA) shed over 13% after hours to US$9.50, as it revealed that candidate Aironite failed to meet the primary endpoint in the Indie Phase 2 clinical study conducted by the Heart Failure Clinical Research Network.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK